Compare, Analyse Panacea Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-18
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs364347-   
Low Rs129251-   
Sales per share (Unadj.) Rs96.8103.3-  
Earnings per share (Unadj.) Rs-12.4-26.0-  
Cash flow per share (Unadj.) Rs-2.9-21.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs50.481.1-  
Shares outstanding (eoy) m61.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.52.9 88.0%   
Avg P/E ratio x-19.9-11.5 173.0%  
P/CF ratio (eoy) x-86.4-13.9 623.9%  
Price / Book Value ratio x4.93.7 132.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,10150,448 29.9%   
No. of employees `0002.54.3 57.5%   
Total wages/salary Rs m1,5163,166 47.9%   
Avg. sales/employee Rs Th2,401.94,061.4 59.1%   
Avg. wages/employee Rs Th614.2737.5 83.3%   
Avg. net profit/employee Rs Th-307.9-1,023.4 30.1%   
INCOME DATA
Net Sales Rs m5,92817,436 34.0%  
Other income Rs m82122 67.4%   
Total revenues Rs m6,01017,558 34.2%   
Gross profit Rs m845-3,021 -28.0%  
Depreciation Rs m585753 77.8%   
Interest Rs m1,006472 213.0%   
Profit before tax Rs m-664-4,124 16.1%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m99258 38.3%   
Profit after tax Rs m-760-4,393 17.3%  
Gross profit margin %14.3-17.3 -82.3%  
Effective tax rate %-14.9-6.2 237.8%   
Net profit margin %-12.8-25.2 50.9%  
BALANCE SHEET DATA
Current assets Rs m5,60312,770 43.9%   
Current liabilities Rs m6,9107,185 96.2%   
Net working cap to sales %-22.032.0 -68.8%  
Current ratio x0.81.8 45.6%  
Inventory Days Days206111 185.6%  
Debtors Days Days84124 67.6%  
Net fixed assets Rs m9,9417,444 133.5%   
Share capital Rs m6181 75.7%   
"Free" reserves Rs m3,0260-   
Net worth Rs m3,08713,685 22.6%   
Long term debt Rs m5,7074,809 118.7%   
Total assets Rs m16,07625,852 62.2%  
Interest coverage x0.3-7.7 -4.4%   
Debt to equity ratio x1.80.4 526.1%  
Sales to assets ratio x0.40.7 54.7%   
Return on assets %1.5-15.2 -10.1%  
Return on equity %-24.6-32.1 76.7%  
Return on capital %3.9-19.8 -19.8%  
Exports to sales %24.00-   
Imports to sales %17.50-   
Net fx Rs m4690-   
CASH FLOW
From Operations Rs m1,1801,488 79.3%  
From Investments Rs m553-457 -121.0%  
From Financial Activity Rs m-1,6444,365 -37.7%  
Net Cashflow Rs m905,396 1.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.79 Rs / ZAR

Compare PANACEA BIOTECH With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: PLETHICO PHARMA  ABBOTT INDIA  FDC LTD.  NOVARTIS  SUVEN LIFESCIENCES  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Oct 17, 2019 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - GSK PHARMA COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS